703 related articles for article (PubMed ID: 14562125)
61. How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.
Béné MC; Kaeda JS
Haematologica; 2009 Aug; 94(8):1135-50. PubMed ID: 19586938
[TBL] [Abstract][Full Text] [Related]
62. [Fluorescence quantitative PCR detection of WT1 gene expression in peripheral blood of patients with acute leukemias and its clinical implications].
Bai B; Wang HW; Xu YQ; Yang HN; Qiao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):610-4. PubMed ID: 16129044
[TBL] [Abstract][Full Text] [Related]
63. Quantification of CBFB-MYH11 fusion gene levels in paired peripheral blood and bone marrow samples by real-time PCR.
Boeckx N; De Roover J; van der Velden VH; Maertens J; Uyttebroeck A; Vandenberghe P; van Dongen JJ
Leukemia; 2005 Nov; 19(11):1988-90. PubMed ID: 16193088
[No Abstract] [Full Text] [Related]
64. Real-time quantitative RT-PCR to detect fusion gene transcripts associated with AML.
Flora R; Grimwade D
Methods Mol Med; 2004; 91():151-73. PubMed ID: 14573936
[No Abstract] [Full Text] [Related]
65. Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform.
Corradi B; Fazio G; Palmi C; Rossi V; Biondi A; Cazzaniga G
Leukemia; 2008 Feb; 22(2):294-302. PubMed ID: 17943166
[TBL] [Abstract][Full Text] [Related]
66. The use of housekeeping genes for real-time PCR-based quantification of fusion gene transcripts in acute myeloid leukemia.
Weisser M; Haferlach T; Schoch C; Hiddemann W; Schnittger S
Leukemia; 2004 Sep; 18(9):1551-3. PubMed ID: 15284861
[No Abstract] [Full Text] [Related]
67. Simultaneous detection of 45 fusion genes in leukemia by dual-color fluorescence real-time PCR.
Zheng Z; Zhang P; He G; Liao K; Wang Z; Pan J; Du K; Du J; Li BA
Int J Lab Hematol; 2017 Apr; 39(2):175-184. PubMed ID: 28133905
[TBL] [Abstract][Full Text] [Related]
68. Overview of real-time RT-PCR strategies for quantification of gene rearrangements in the myeloid malignancies.
Picard C; Silvy M; Gabert J
Methods Mol Med; 2006; 125():27-68. PubMed ID: 16502577
[TBL] [Abstract][Full Text] [Related]
69. Gene expression profiling for the diagnosis of acute leukaemia.
Haferlach T; Kohlmann A; Bacher U; Schnittger S; Haferlach C; Kern W
Br J Cancer; 2007 Feb; 96(4):535-40. PubMed ID: 17146476
[TBL] [Abstract][Full Text] [Related]
70. Analysis of Wilms tumor gene (WT1) expression in acute leukemia patients with special reference to the differential diagnosis between eosinophilic leukemia and idiopathic hypereosinophilic syndromes.
Menssen HD; Schmidt A; Bartelt S; Arjomand A; Thomsen H; Leben R; Kath R; Thiel E
Leuk Lymphoma; 2000 Jan; 36(3-4):285-94. PubMed ID: 10674900
[TBL] [Abstract][Full Text] [Related]
71. [RT-PCR detecting NUP98-HOX fusion gene in leukemia].
Zhang Y; Li L; Wen BZ; Lin RY; Cao X; Wang N; Ha Li Da YS; Jiang M; Wen H; Lu XM; Feng XH; Wang X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):83-7. PubMed ID: 15748441
[TBL] [Abstract][Full Text] [Related]
72. Multiplex fluorescent RT-PCR to quantify leukemic fusion transcripts.
Dupont M; Goldsborough A; Levayer T; Savare J; Rey JM; Rossi JF; Demaille J; Lavabre-Bertrand T
Biotechniques; 2002 Jul; 33(1):158-60, 162, 164. PubMed ID: 12139241
[TBL] [Abstract][Full Text] [Related]
73. Reliability of PCR-based detection of occult tumour cells: lessons from real-time RT-PCR.
Max N; Willhauck M; Wolf K; Thilo F; Reinhold U; Pawlita M; Thiel E; Keilholz U
Melanoma Res; 2001 Aug; 11(4):371-8. PubMed ID: 11479425
[TBL] [Abstract][Full Text] [Related]
74. Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes.
Tsuchiya K; Tabe Y; Ai T; Ohkawa T; Usui K; Yuri M; Misawa S; Morishita S; Takaku T; Kakimoto A; Yang H; Matsushita H; Hanami T; Yamanaka Y; Okuzawa A; Horii T; Hayashizaki Y; Ohsaka A
PLoS One; 2018; 13(10):e0202429. PubMed ID: 30281597
[TBL] [Abstract][Full Text] [Related]
75. Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia.
Olesen LH; Nørgaard JM; Pallisgaard N; Bukh A; Hokland P
Eur J Haematol; 2003 May; 70(5):296-303. PubMed ID: 12694165
[TBL] [Abstract][Full Text] [Related]
76. Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro.
Asadi-Azarbaijani B; Sheikhi M; Nurmio M; Tinkanen H; Juvonen V; Dunkel L; Hovatta O; Oskam IC; Jahnukainen K
Leuk Lymphoma; 2016; 57(3):700-7. PubMed ID: 26122194
[TBL] [Abstract][Full Text] [Related]
77. Diagnosis and monitoring of CBFB-MYH11-positive acute myeloid leukemia by qualitative and quantitative RT-PCR.
van der Reijden BA; Jansen JH
Methods Mol Med; 2006; 125():163-75. PubMed ID: 16502584
[TBL] [Abstract][Full Text] [Related]
78. Evaluation of real-time quantitative PCR machines for the monitoring of fusion gene transcripts using the Europe against cancer protocol.
Silvy M; Mancini J; Thirion X; Sigaux F; Gabert J
Leukemia; 2005 Feb; 19(2):305-7. PubMed ID: 15618967
[No Abstract] [Full Text] [Related]
79. Minimal residual disease testing in hematologic malignancies and solid cancer.
Ben Lassoued A; Nivaggioni V; Gabert J
Expert Rev Mol Diagn; 2014 Jul; 14(6):699-712. PubMed ID: 24938122
[TBL] [Abstract][Full Text] [Related]
80. Microfluidics-Based PCR for Fusion Transcript Detection.
Chen H
Methods Mol Biol; 2016; 1392():103-11. PubMed ID: 26843050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
